Novartis axes UK transplant centre

Jessa Netting

Nature, 2000, vol. 407, issue 6804, 547-547

Abstract: Swiss drug company Novartis is set to sidestep mounting controversy over its xenotransplantation record in Britain by shutting its UK subsidiary Imutran.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35036712 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:407:y:2000:i:6804:d:10.1038_35036712

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35036712

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().